N-3-substituted imidazoquinazolinones: Potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction

David P. Rotella; Zhong Sun; Yeheng Zhu; John Krupinski; Ronald Pongrac; Laurie Seliger; Diane Normandin; John E. Macor

doi:10.1021/jm000081+

N-3-substituted imidazoquinazolinones: Potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction

David P. Rotella, Zhong Sun, Yeheng Zhu, John Krupinski, Ronald Pongrac, Laurie Seliger, Diane Normandin, John E. Macor

Chemistry and Biochemistry

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Abstract

Phosphodiesterase type 5 (PDE5) inhibitors with improved PDE isozyme selectivity relative to sildenafil may result in agents for the treatment of male erectile dysfunction (MED) with a lower incidence of PDE-associated adverse effects. This paper describes the discovery of 14, a PDE5 inhibitor with improved potency and selectivity in vitro compared to sildenafil. This compound shows activity in a functional assay of erectile function comparable to that of sildenafil.

Original language	English
Pages (from-to)	1257-1263
Number of pages	7
Journal	Journal of Medicinal Chemistry
Volume	43
Issue number	7
DOIs	https://doi.org/10.1021/jm000081+
State	Published - 6 Apr 2000

Access to Document

10.1021/jm000081+

Cite this

@article{fecd3b9bc13041f881405e1bcbfe5295,

title = "N-3-substituted imidazoquinazolinones: Potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction",

abstract = "Phosphodiesterase type 5 (PDE5) inhibitors with improved PDE isozyme selectivity relative to sildenafil may result in agents for the treatment of male erectile dysfunction (MED) with a lower incidence of PDE-associated adverse effects. This paper describes the discovery of 14, a PDE5 inhibitor with improved potency and selectivity in vitro compared to sildenafil. This compound shows activity in a functional assay of erectile function comparable to that of sildenafil.",

author = "Rotella, \{David P.\} and Zhong Sun and Yeheng Zhu and John Krupinski and Ronald Pongrac and Laurie Seliger and Diane Normandin and Macor, \{John E.\}",

year = "2000",

month = apr,

day = "6",

doi = "10.1021/jm000081+",

language = "English",

volume = "43",

pages = "1257--1263",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "7",

}

TY - JOUR

T1 - N-3-substituted imidazoquinazolinones

T2 - Potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction

AU - Rotella, David P.

AU - Sun, Zhong

AU - Zhu, Yeheng

AU - Krupinski, John

AU - Pongrac, Ronald

AU - Seliger, Laurie

AU - Normandin, Diane

AU - Macor, John E.

PY - 2000/4/6

Y1 - 2000/4/6

N2 - Phosphodiesterase type 5 (PDE5) inhibitors with improved PDE isozyme selectivity relative to sildenafil may result in agents for the treatment of male erectile dysfunction (MED) with a lower incidence of PDE-associated adverse effects. This paper describes the discovery of 14, a PDE5 inhibitor with improved potency and selectivity in vitro compared to sildenafil. This compound shows activity in a functional assay of erectile function comparable to that of sildenafil.

AB - Phosphodiesterase type 5 (PDE5) inhibitors with improved PDE isozyme selectivity relative to sildenafil may result in agents for the treatment of male erectile dysfunction (MED) with a lower incidence of PDE-associated adverse effects. This paper describes the discovery of 14, a PDE5 inhibitor with improved potency and selectivity in vitro compared to sildenafil. This compound shows activity in a functional assay of erectile function comparable to that of sildenafil.

UR - https://www.scopus.com/pages/publications/0034611619

U2 - 10.1021/jm000081+

DO - 10.1021/jm000081+

M3 - Article

C2 - 10753463

AN - SCOPUS:0034611619

SN - 0022-2623

VL - 43

SP - 1257

EP - 1263

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 7

ER -

N-3-substituted imidazoquinazolinones: Potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction

Abstract

Access to Document

Other files and links

Fingerprint

Cite this